查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1942606

2026年全球连续血糖值监测市场报告

Continuous Glucose Monitoring Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，持续血糖监测市场发展迅速，预计将从2025年的94.4亿美元成长到2026年的108.7亿美元，复合年增长率达15.1%。过去几年成长要素包括即时血糖监测设备供不应求、初始持续血糖监测设备高成本、糖尿病管理意识不断提高、对指尖采血检测的依赖以及医院越来越多地采用监测解决方案。

预计未来几年，持续血糖监测市场将快速成长，到2030年市场规模将达到188.6亿美元，复合年增长率（CAGR）为14.8%。预测期内的成长要素包括植入式和穿戴式感测器技术的进步、与行动医疗和远端医疗平台的整合、全球糖尿病患者人数的成长、非侵入性血糖监测技术的进步以及居家医疗和远端患者监护服务的扩展。预测期内的主要趋势包括糖尿病患者对持续血糖监测设备的日益普及、微创和植入式感测器的发展、与即时数据分析和警报系统的整合、家庭监测和远端医疗解决方案的扩展，以及对儿童和老年人血糖监测解决方案需求的增长。

预计未来几年，糖尿病盛行率的不断上升将推动持续血糖监测市场的成长。糖尿病是一种慢性疾病，患者体内胰岛素分泌不足或无法有效利用自身产生的胰岛素，导致血糖值升高。糖尿病患者数量的增加主要是由于不健康的饮食习惯，例如高糖、高脂肪和高加工食品的摄入，这些因素会导致肥胖和胰岛素功能受损。持续血糖监测透过提供血糖值水平的即时变化趋势来辅助糖尿病管理，使患者能够及时调整饮食、药物和运动量，有助于改善血糖控制。例如，根据美国非营利组织美国糖尿病协会发布的数据，到2022年，美国糖尿病患者人数将达到约2,550万人（约占总人口的7.6%），比前一年增长3%。糖尿病患者数量的成长趋势正在推动持续血糖监测市场的成长。

持续血糖监测市场的主要企业正致力于开发创新产品，例如基于感测器的血糖监测仪，以提高准确性、即时追踪功能和患者便利性。基于感测器的血糖监测仪使用植入皮下的小型感测器持续测量血糖值。例如，2024年8月，美国医疗公司德康（Dexcom）推出了Stello，这是第一款专为不使用胰岛素的成年人设计的非处方（OTC）持续血糖监测仪（CGM）。 Stello使用佩戴在上臂后侧的小型感测器，无需处方笺或指尖采血，即可全天候将即时血糖值数据直接传输到智慧型手机。该设备提供个人化分析和趋势分析，帮助患者了解饮食、运动和睡眠等因素如何影响血糖值血糖值。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球连续血糖监测市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 数位化、云端运算、巨量资料、网路安全
    • 物联网、智慧基础设施和互联生态系统
    • 工业4.0和智慧製造
    • 人工智慧（AI）和自主人工智慧
  • 主要趋势
    • 持续血糖监测设备在糖尿病患者中越来越受欢迎
    • 开发微创植入式感测器
    • 即时数据分析与警报系统集成
    • 扩展家庭监测和远端医疗解决方案
    • 儿童和老年人血糖监测解决方案的需求不断增长

第五章 终端用户产业市场分析

  • 医院
  • 居家护理患者
  • 诊断中心和诊所
  • 糖尿病管理计划
  • 研究和学术机构

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球连续血糖监测市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球连续血糖监测市场规模、比较及成长率分析
  • 全球连续血糖监测市场表现：规模与成长，2020-2025年
  • 全球连续血糖监测市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球总潜在市场（TAM）

第九章 市场细分

  • 按组件
  • 发送器、感测器、接收器
  • 按年龄组
  • 成人和儿童
  • 按最终用途
  • 医院、居家医疗环境、诊断中心和诊所及其他终端用途
  • 按类型细分：发送器
  • 发送器、一次性使用和可充电发送器
  • 按类型细分：感测器
  • 植入式感测器、经皮感测器、一次性感测器、即时感测器
  • 按类型细分：接收器
  • 独立接收器、整合式接收器、穿戴式显示设备

第十章 区域与国家分析

  • 全球连续血糖监测市场：按地区、效能和预测划分，2020-2025年、2025-2030年预测、2035年预测
  • 全球连续血糖监测市场：按国家、表现和预测划分，2020-2025 年、2025-2030 年预测、2035 年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 连续血糖监测市场：竞争格局及市场占有率（2024年）
  • 连续血糖监测市场：公司估值矩阵
  • 连续血糖监测市场：公司简介
    • Roche Diabetes Care
    • Abbott Laboratories
    • Medtronic plc
    • Dexcom Inc
    • Insulet Corporation

第37章：其他领先和创新企业

  • Tandem Diabetes Care Inc, Ypsomed AG, Nova Biomedical, Ascensia Diabetes Care, Bionime Corporation, Biolinq Inc, Beta Bionics Inc, AgaMatrix Inc, A Menarini Diagnostics SRL, Senseonics Holdings Inc, Medtrum Technologies Inc, Nemaura Medical Inc, LifeScan Inc, EOFlow Co Ltd, POCTech Co Ltd

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年连续血糖监测市场：提供新机会的国家
  • 2030年连续血糖监测市场：新兴细分市场机会
  • 2030年连续血糖监测市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MCGML02_G26Q1

Continuous glucose monitoring (CGM) is a medical technology that continuously measures glucose levels in real time throughout the day and night using a small sensor placed under the skin. It assists people with diabetes in managing their condition by providing ongoing data and alerts for high or low blood sugar levels.

The key components of continuous glucose monitoring systems include transmitters, sensors, and receivers. Transmitters are devices that send signals, such as radio waves or electrical impulses, from one point to another for communication or control. These systems are utilized by both adults and children and cater to a range of end users, including hospitals, home care environments, diagnostic centers, clinics, and other healthcare facilities.

Tariffs have influenced the continuous glucose monitoring market by increasing the cost of imported sensors, transmitters, and wearable receivers, particularly affecting advanced and real-time monitoring systems. Regions such as North America and Asia-Pacific, where significant imports occur, are most impacted. This has led to higher device costs and delayed adoption in certain markets. On the positive side, tariffs encourage local manufacturing, innovation in sensor technology, and investment in domestic supply chains, which can improve long-term market resilience and accessibility.

The continuous glucose monitoring market research report is one of a series of new reports from The Business Research Company that provides continuous glucose monitoring market statistics, including continuous glucose monitoring industry global market size, regional shares, competitors with a continuous glucose monitoring market share, detailed continuous glucose monitoring market segments, market trends and opportunities, and any further data you may need to thrive in the continuous glucose monitoring industry. This continuous glucose monitoring market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The continuous glucose monitoring market size has grown rapidly in recent years. It will grow from $9.44 billion in 2025 to $10.87 billion in 2026 at a compound annual growth rate (CAGR) of 15.1%. The growth in the historic period can be attributed to limited availability of real-time glucose monitoring devices, high cost of early cgms, growing awareness of diabetes management, dependence on finger-prick testing, increasing hospital adoption of monitoring solutions.

The continuous glucose monitoring market size is expected to see rapid growth in the next few years. It will grow to $18.86 billion in 2030 at a compound annual growth rate (CAGR) of 14.8%. The growth in the forecast period can be attributed to advancement in implantable and wearable sensors, integration with mobile health and telemedicine platforms, rising prevalence of diabetes globally, development of non-invasive glucose monitoring technology, expansion of home healthcare and remote patient monitoring services. Major trends in the forecast period include growing adoption of continuous glucose monitoring devices among diabetic patients, development of minimally invasive and implantable sensors, integration of real-time data analytics and alert systems, expansion of home-based monitoring and telehealth solutions, rising demand for pediatric and geriatric glucose monitoring solutions.

The increasing prevalence of diabetes is expected to drive the growth of the continuous glucose monitoring market in the coming years. Diabetes is a chronic condition where the body either produces insufficient insulin or cannot effectively use the insulin it produces, leading to elevated blood sugar (glucose) levels. This rise in diabetes cases is mainly due to unhealthy diets rich in sugars, fats, and processed foods, which contribute to obesity and impaired insulin function. Continuous glucose monitoring supports diabetes management by providing real-time blood sugar trends, allowing timely adjustments to diet, medication, and physical activity for better glucose control. For example, in November 2023, the American Diabetes Association, a U.S.-based non-profit organization, reported that in 2022, approximately 25.5 million people in the U.S.-about 7.6% of the population-were diagnosed with diabetes, marking a 3% increase compared to previous years. Thus, the rising prevalence of diabetes is fueling growth in the continuous glucose monitoring market.

Leading companies in the continuous glucose monitoring market are focusing on developing innovative products such as sensor-based glucose monitors to improve accuracy, real-time tracking, and patient convenience. Sensor-based glucose monitors continuously measure blood sugar levels using a small sensor inserted under the skin. For example, in August 2024, DexCom, Inc., a U.S.-based healthcare company, launched Stelo, the first over-the-counter (OTC) continuous glucose monitor (CGM) designed for adults who do not use insulin. Stelo provides real-time, 24/7 glucose readings via a small sensor worn on the back of the upper arm, sending data directly to a smartphone without the need for a prescription or fingersticks. The device offers personalized insights and trend analysis, helping users understand how factors such as diet, exercise, and sleep affect their glucose levels, enabling smarter lifestyle decisions. The sensor lasts up to 15 days, integrates with health apps, and is ideal for people with Type 2 diabetes not using insulin, those with prediabetes, or anyone monitoring their glucose health.

In September 2023, Abbott Laboratories, a U.S.-based healthcare company, acquired Bigfoot Biomedical for an undisclosed sum. Through this acquisition, Abbott seeks to strengthen its position in diabetes care by enhancing its Freestyle Libre continuous glucose monitoring technology and advancing connected solutions to make diabetes management more personalized and precise. Bigfoot Biomedical Inc., also based in the U.S., is a medical technology company that provides a diabetes management system integrating continuous glucose monitoring (CGM) technology.

Major companies operating in the continuous glucose monitoring market are Roche Diabetes Care, Abbott Laboratories, Medtronic plc, Dexcom Inc, Insulet Corporation, Tandem Diabetes Care Inc, Ypsomed AG, Nova Biomedical, Ascensia Diabetes Care, Bionime Corporation, Biolinq Inc, Beta Bionics Inc, AgaMatrix Inc, A Menarini Diagnostics SRL, Senseonics Holdings Inc, Medtrum Technologies Inc, Nemaura Medical Inc, LifeScan Inc, EOFlow Co Ltd, POCTech Co Ltd

North America was the largest region in the continuous glucose monitoring market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the continuous glucose monitoring market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the continuous glucose monitoring market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The continuous glucose monitoring market consists of revenues earned by entities by providing services such as real-time glucose tracking, remote patient monitoring, and data analytics for personalized diabetes management. The market value includes the value of related goods sold by the service provider or included within the service offering. The continuous glucose monitoring market also includes sales of Integrated insulin pumps, mobile and wearable apps and cloud-based data management platforms. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Continuous Glucose Monitoring Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses continuous glucose monitoring market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for continuous glucose monitoring ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The continuous glucose monitoring market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Component: Transmitters; Sensors; Receivers
  • 2) By Age Group: Adults; Children
  • 3) By End Use: Hospitals; Home Care Settings; Diagnostic Centers And Clinics; Other End Uses
  • Subsegments:
  • 1) By Transmitters: Reusable Transmitters; Disposable Transmitters; Rechargeable Transmitters
  • 2) By Sensors: Implantable Sensors; Transcutaneous Sensors; Disposable Sensors; Real-Time Sensors
  • 3) By Receivers: Standalone Receivers; Integrated Receivers; Wearable Display Devices
  • Companies Mentioned: Roche Diabetes Care; Abbott Laboratories; Medtronic plc; Dexcom Inc; Insulet Corporation; Tandem Diabetes Care Inc; Ypsomed AG; Nova Biomedical; Ascensia Diabetes Care; Bionime Corporation; Biolinq Inc; Beta Bionics Inc; AgaMatrix Inc; A Menarini Diagnostics SRL; Senseonics Holdings Inc; Medtrum Technologies Inc; Nemaura Medical Inc; LifeScan Inc; EOFlow Co Ltd; POCTech Co Ltd
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Continuous Glucose Monitoring Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Continuous Glucose Monitoring Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Continuous Glucose Monitoring Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Continuous Glucose Monitoring Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Artificial Intelligence & Autonomous Intelligence
  • 4.2. Major Trends
    • 4.2.1 Growing Adoption Of Continuous Glucose Monitoring Devices Among Diabetic Patients
    • 4.2.2 Development Of Minimally Invasive And Implantable Sensors
    • 4.2.3 Integration Of Real-Time Data Analytics And Alert Systems
    • 4.2.4 Expansion Of Home-Based Monitoring And Telehealth Solutions
    • 4.2.5 Rising Demand For Pediatric And Geriatric Glucose Monitoring Solutions

5. Continuous Glucose Monitoring Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Home Care Patients
  • 5.3 Diagnostic Centers And Clinics
  • 5.4 Diabetes Management Programs
  • 5.5 Research And Academic Institutions

6. Continuous Glucose Monitoring Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Continuous Glucose Monitoring Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Continuous Glucose Monitoring PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Continuous Glucose Monitoring Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Continuous Glucose Monitoring Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Continuous Glucose Monitoring Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Continuous Glucose Monitoring Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Continuous Glucose Monitoring Market Segmentation

  • 9.1. Global Continuous Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Transmitters, Sensors, Receivers
  • 9.2. Global Continuous Glucose Monitoring Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Adults, Children
  • 9.3. Global Continuous Glucose Monitoring Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Home Care Settings, Diagnostic Centers And Clinics, Other End Uses
  • 9.4. Global Continuous Glucose Monitoring Market, Sub-Segmentation Of Transmitters, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Reusable Transmitters, Disposable Transmitters, Rechargeable Transmitters
  • 9.5. Global Continuous Glucose Monitoring Market, Sub-Segmentation Of Sensors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Implantable Sensors, Transcutaneous Sensors, Disposable Sensors, Real-Time Sensors
  • 9.6. Global Continuous Glucose Monitoring Market, Sub-Segmentation Of Receivers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Standalone Receivers, Integrated Receivers, Wearable Display Devices

10. Continuous Glucose Monitoring Market Regional And Country Analysis

  • 10.1. Global Continuous Glucose Monitoring Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Continuous Glucose Monitoring Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Continuous Glucose Monitoring Market

  • 11.1. Asia-Pacific Continuous Glucose Monitoring Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Continuous Glucose Monitoring Market, Segmentation By Component, Segmentation By Age Group, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Continuous Glucose Monitoring Market

  • 12.1. China Continuous Glucose Monitoring Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Continuous Glucose Monitoring Market, Segmentation By Component, Segmentation By Age Group, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Continuous Glucose Monitoring Market

  • 13.1. India Continuous Glucose Monitoring Market, Segmentation By Component, Segmentation By Age Group, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Continuous Glucose Monitoring Market

  • 14.1. Japan Continuous Glucose Monitoring Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Continuous Glucose Monitoring Market, Segmentation By Component, Segmentation By Age Group, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Continuous Glucose Monitoring Market

  • 15.1. Australia Continuous Glucose Monitoring Market, Segmentation By Component, Segmentation By Age Group, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Continuous Glucose Monitoring Market

  • 16.1. Indonesia Continuous Glucose Monitoring Market, Segmentation By Component, Segmentation By Age Group, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Continuous Glucose Monitoring Market

  • 17.1. South Korea Continuous Glucose Monitoring Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Continuous Glucose Monitoring Market, Segmentation By Component, Segmentation By Age Group, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Continuous Glucose Monitoring Market

  • 18.1. Taiwan Continuous Glucose Monitoring Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Continuous Glucose Monitoring Market, Segmentation By Component, Segmentation By Age Group, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Continuous Glucose Monitoring Market

  • 19.1. South East Asia Continuous Glucose Monitoring Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Continuous Glucose Monitoring Market, Segmentation By Component, Segmentation By Age Group, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Continuous Glucose Monitoring Market

  • 20.1. Western Europe Continuous Glucose Monitoring Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Continuous Glucose Monitoring Market, Segmentation By Component, Segmentation By Age Group, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Continuous Glucose Monitoring Market

  • 21.1. UK Continuous Glucose Monitoring Market, Segmentation By Component, Segmentation By Age Group, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Continuous Glucose Monitoring Market

  • 22.1. Germany Continuous Glucose Monitoring Market, Segmentation By Component, Segmentation By Age Group, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Continuous Glucose Monitoring Market

  • 23.1. France Continuous Glucose Monitoring Market, Segmentation By Component, Segmentation By Age Group, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Continuous Glucose Monitoring Market

  • 24.1. Italy Continuous Glucose Monitoring Market, Segmentation By Component, Segmentation By Age Group, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Continuous Glucose Monitoring Market

  • 25.1. Spain Continuous Glucose Monitoring Market, Segmentation By Component, Segmentation By Age Group, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Continuous Glucose Monitoring Market

  • 26.1. Eastern Europe Continuous Glucose Monitoring Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Continuous Glucose Monitoring Market, Segmentation By Component, Segmentation By Age Group, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Continuous Glucose Monitoring Market

  • 27.1. Russia Continuous Glucose Monitoring Market, Segmentation By Component, Segmentation By Age Group, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Continuous Glucose Monitoring Market

  • 28.1. North America Continuous Glucose Monitoring Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Continuous Glucose Monitoring Market, Segmentation By Component, Segmentation By Age Group, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Continuous Glucose Monitoring Market

  • 29.1. USA Continuous Glucose Monitoring Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Continuous Glucose Monitoring Market, Segmentation By Component, Segmentation By Age Group, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Continuous Glucose Monitoring Market

  • 30.1. Canada Continuous Glucose Monitoring Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Continuous Glucose Monitoring Market, Segmentation By Component, Segmentation By Age Group, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Continuous Glucose Monitoring Market

  • 31.1. South America Continuous Glucose Monitoring Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Continuous Glucose Monitoring Market, Segmentation By Component, Segmentation By Age Group, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Continuous Glucose Monitoring Market

  • 32.1. Brazil Continuous Glucose Monitoring Market, Segmentation By Component, Segmentation By Age Group, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Continuous Glucose Monitoring Market

  • 33.1. Middle East Continuous Glucose Monitoring Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Continuous Glucose Monitoring Market, Segmentation By Component, Segmentation By Age Group, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Continuous Glucose Monitoring Market

  • 34.1. Africa Continuous Glucose Monitoring Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Continuous Glucose Monitoring Market, Segmentation By Component, Segmentation By Age Group, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Continuous Glucose Monitoring Market Regulatory and Investment Landscape

36. Continuous Glucose Monitoring Market Competitive Landscape And Company Profiles

  • 36.1. Continuous Glucose Monitoring Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Continuous Glucose Monitoring Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Continuous Glucose Monitoring Market Company Profiles
    • 36.3.1. Roche Diabetes Care Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Dexcom Inc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Insulet Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Continuous Glucose Monitoring Market Other Major And Innovative Companies

  • Tandem Diabetes Care Inc, Ypsomed AG, Nova Biomedical, Ascensia Diabetes Care, Bionime Corporation, Biolinq Inc, Beta Bionics Inc, AgaMatrix Inc, A Menarini Diagnostics SRL, Senseonics Holdings Inc, Medtrum Technologies Inc, Nemaura Medical Inc, LifeScan Inc, EOFlow Co Ltd, POCTech Co Ltd

38. Global Continuous Glucose Monitoring Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Continuous Glucose Monitoring Market

40. Continuous Glucose Monitoring Market High Potential Countries, Segments and Strategies

  • 40.1 Continuous Glucose Monitoring Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Continuous Glucose Monitoring Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Continuous Glucose Monitoring Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer